SNDX

Syndax Pharmaceuticals Inc (SNDX)

US
$ 13.330.23%

Price Chart

Key Statistics

Market Cap
$ 800.24M
P/E Ratio
0.00
Revenue (TTM)
$ 43.72M
Volume
716.52K
52W High
$ 25.07
52W Low
$ 8.58
Dividend Yield
0.00%
Beta
0.82

Technicals

50-Day MA
12.1239
200-Day MA
15.7863
52 Week High
25.07
52 Week Low
8.58

About SNDX

Syndax Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, develops therapies for the treatment of cancer.

Employees
270
Headquarters
New York, NY
CEO
Mr. Michael A. Metzger M.B.A.

Latest News

Advanced Charts

Access professional-grade trading charts and technical analysis tools

Top Gainers

Symbol/Name
LTP
% Chg
BLMZ
BloomZ Inc. Ordinar...
$ 0.24
136.74
EDBL
Edible Garden AG In...
$ 4.02
101.00
SYTA
Siyata Mobile Inc. ...
$ 7.69
88.94
TNMG
TNL Mediagene Ordin...
$ 1.03
72.85
NRXS
Neuraxis Inc. Commo...
$ 3.75
65.20

Top Losers

Symbol/Name
LTP
% Chg
PTIX
Protagenic Therapeu...
$ 6.16
-44.50
NWTN
NWTN Inc. Class B O...
$ 2.39
-21.90
KIDZ
Classover Holdings ...
$ 2.70
-11.48
BCLI
Brainstorm Cell The...
$ 1.21
-11.03
TGL
Treasure Global Inc...
$ 1.61
-10.56